相关实验视频

Updated: Jul 11, 2026

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Ultrasonographic Evaluation of Breast Cancer-related Lymphedema

Published on: January 12, 2017

肥胖患者乳腺切除术后的乳房重建:叙事性综述

Priscila Cevallos^1,2, Charlotte Berry¹, Kelsey Jordan Lipman¹

¹Division of Plastic and Reconstructive Surgery, Stanford University, Palo Alto, CA, USA.

Annals of translational medicine

|January 12, 2024

概括

针对肥胖患者的乳房重建提供了扩展的选择,如基于植入物的自主或混合技术. 仔细的评估确保了尽管有手术的挑战,有利的结果.

科学领域:

整形外科整形外科整形外科
瘤外科手术瘤外科手术
重建性手术是一种重建性手术.

背景情况:

肥胖在乳房重建手术和手术后护理中提出了独特的挑战.
不断发展的技术已经扩大了肥胖患者的重建选择.

研究的目的:

总结当前的文献指导外科医生对肥胖患者的乳房重建.
审查可用的重建选择及其考虑.

主要方法:

在PubMed.com上进行了全面的文献搜索.
包括1990年至2023年间发表的英语语言研究.
通过参考文献审查和网络搜索确定了其他文章.

主要成果:

扩展的手术选择包括立即或延迟的基于植入物的自主或混合乳房重建.
每种方法都有不同的优点,缺点和手术考虑.
通过仔细评估并发症和期望管理,可以实现有利的审美结果.

结论:

肥胖患者的乳房重建需要细微的决策.
瘤和重建手术的进步提供了多样化的选择.
仔细的患者评估是成功结果的关键.

关键词:

乳房重建乳房重建身体质量指数 (BMI) 是指身体质量指数.肥胖肥胖肥胖肥胖肥胖肥胖肥胖肥胖

更多相关视频

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion

Published on: February 14, 2025

相关概念视频

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...